Epigenetics Market | Known and Unknown Adjacencies Impacting the Market

Pune, India, 2020-Jan-30 — /EPR Network/ —

Epigenetics refers to the covalent modification of DNA, RNA, or protein that results in changes to the function and/or regulation of these molecules, without altering their primary sequences. These modifications can occur naturally, or can be influenced, by several factors including age, environment, disease state, and changes in lifestyle.

Epigenetic changes such as dysregulation of DNA methylation are associated with cancer development and progression. Epigenetics provides new opportunities for deriving therapeutic strategies designed to reverse dysregulation in cancer. Several cancer research studies that utilize epigenetics techniques are currently underway; significant investments are being made to support these researches. The increasing prevalence of cancer will drive epigenetics research focused on this condition which will drive growth in epigenetics market.

Pharmaceutical companies and research laboratories require many such systems. Therefore, significant investments are required for procuring multiple, high-cost genomic instruments. End users such as academic research laboratories find it difficult to afford such systems as they have constricted budgets. High instrument costs, therefore, hinder their wide adoption, which is expected to restrict market growth during the forecast period.

The global epigenetics market is projected to reach USD 1.60 billion by 2022 from USD 0.85 billion in 2017, growing at a CAGR of 13.3% during the forecast period. Decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases are the factors contributing for the growth of this market.

Browse 191 market data Tables and 37 Figures spread through 230 Pages.
Download PDF Brochure Now: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=896

Segmentation of Epigenetics Market:

1. Product
2. Application
3. Technology
4. End Users
5. Region

Epigenetics Kits accounted for the largest share of this market mainly because a large number of kits are used in various epigenetics techniques. Currently, several companies are providing easy-to-use kits for studying epigenetic processes such as DNA methylation and histone modifications. The growing prevalence of several diseases and the increasing number of R&D activities in epigenetics and genomics are leading to an increase in the use of kit-based products.

Regional Analysis:

The epigenetics market in Asia-Pacific region is expected to witness the highest CAGR during the forecast period of 2017 to 2022. The growth of this segment can be attributed to the increasing R&D spending, increasing government initiatives, and rising focus on key market players in the region. Emerging markets such as Brazil, China, and India offer significant growth potential to market players.

Leading Market Players:

The prominent players of this market are Illumina (US), Thermo Fisher (US), Diagenode (Belgium), QIAGEN (Netherlands), Merck Millipore (US), Abcam (UK), Active Motif (US), New England Biolabs (US), Agilent (US), Zymo Research (US), PerkinElmer (US), Bio-Rad (US). These companies are pursuing several organic and inorganic growth strategies such as acquisitions, collaboration, partnerships, agreements, expansions, and product launches.

Matched content

Editor’s pick

Express Press Release Distribution